Suzanne J. Pickering

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications

Disentangling the drivers of heterogeneity in SARS-CoV-2 transmission from data on viral load and daily contact rates.

Disentangling the drivers of heterogeneity in SARS-CoV-2 transmission from data on viral load and daily contact rates.

Journal: PLoS computational biology
Published: September 26, 2025

Antibody escape drives emergence of diverse spike haplotypes resembling variants of concern in persistent SARS-CoV-2 infections.

Antibody escape drives emergence of diverse spike haplotypes resembling variants of concern in persistent SARS-CoV-2 infections.

Journal: Cell reports. Medicine
Published: June 18, 2025

KCL TEST: an open-source inspired asymptomatic SARS-CoV-2 surveillance programme in an academic institution.

KCL TEST: an open-source inspired asymptomatic SARS-CoV-2 surveillance programme in an academic institution.

Journal: Biology methods & protocols
Published: February 20, 2024

Antibodies to the RBD of SARS-CoV-2 spike mediate productive infection of primary human macrophages.

Antibodies to the RBD of SARS-CoV-2 spike mediate productive infection of primary human macrophages.

Journal: Nature communications
Published: November 07, 2023

Differential dysregulation of β-TrCP1 and -2 by HIV-1 Vpu leads to inhibition of canonical and non-canonical NF-κB pathways in infected cells.

Differential dysregulation of β-TrCP1 and -2 by HIV-1 Vpu leads to inhibition of canonical and non-canonical NF-κB pathways in infected cells.

Journal: mBio
Published: June 21, 2023

The P681H Mutation in the Spike Glycoprotein of the Alpha Variant of SARS-CoV-2 Escapes IFITM Restriction and Is Necessary for Type I Interferon Resistance.

The P681H Mutation in the Spike Glycoprotein of the Alpha Variant of SARS-CoV-2 Escapes IFITM Restriction and Is Necessary for Type I Interferon Resistance.

Journal: Journal of virology
Published: November 09, 2022

A neutralizing epitope on the SD1 domain of SARS-CoV-2 spike targeted following infection and vaccination.

A neutralizing epitope on the SD1 domain of SARS-CoV-2 spike targeted following infection and vaccination.

Journal: Cell reports
Published: March 28, 2022

Disrupted Peyer's Patch Microanatomy in COVID-19 Including Germinal Centre Atrophy Independent of Local Virus.

Disrupted Peyer's Patch Microanatomy in COVID-19 Including Germinal Centre Atrophy Independent of Local Virus.

Journal: Frontiers in immunology
Published: December 17, 2021

ChAdOx1 nCoV-19 vaccine elicits monoclonal antibodies with cross-neutralizing activity against SARS-CoV-2 viral variants.

ChAdOx1 nCoV-19 vaccine elicits monoclonal antibodies with cross-neutralizing activity against SARS-CoV-2 viral variants.

Journal: Cell reports
Published: September 24, 2021

Real-world deployment of lateral flow SARS-CoV-2 antigen detection in the emergency department to provide rapid, accurate and safe diagnosis of COVID-19.

Real-world deployment of lateral flow SARS-CoV-2 antigen detection in the emergency department to provide rapid, accurate and safe diagnosis of COVID-19.

Journal: Infection prevention in practice
Published: August 23, 2021

Comparative performance of SARS-CoV-2 lateral flow antigen tests and association with detection of infectious virus in clinical specimens: a single-centre laboratory evaluation study.

Comparative performance of SARS-CoV-2 lateral flow antigen tests and association with detection of infectious virus in clinical specimens: a single-centre laboratory evaluation study.

Journal: The Lancet. Microbe
Published: July 06, 2021

Antibody longevity and cross-neutralizing activity following SARS-CoV-2 wave 1 and B.1.1.7 infections.

Antibody longevity and cross-neutralizing activity following SARS-CoV-2 wave 1 and B.1.1.7 infections.

Journal: medRxiv : the preprint server for health sciences
Published: June 15, 2021
Showing 1-12 of 33

Last Updated: 09/26/2026